Proviv is a privately held biotech/agriculture company based in Santa Monica, California. It develops natural and affordable pheromone products for usage in pest control and crop protection. The compounds elicit non-lethal, species specific insect control through disrupting mating cycles, thereby resulting in lower insect pest population and less crop damage and losses.
In April 2018, Provivi announced its U.S. EPA registration approval for its first pheromone active ingredient, Proviv Z-9-Tetradecenyl Acetate, and also its first end-use product, Provivi FAW Dispenser. In November 2018, the company announced a multi-year supply agreement for its pheromone based pest control products with a leading agriculture company.
Provivi raises a $85,000,000 series C round from Pontifax AgTech, Kairos Venture Investments, BASF, Spruce Capital Partners, Tybourne Capital Management and Lanx Capital.
Director - HR & Operations
Director - Formulation Chemistry
Global Supply Chain Manager
Director - Entomology
Senior VP of Chemistry & Biocatalysis
Director - Metabolic Engineering
VP of IP, Licensing, & Legal
Global Business Director
Lily (Xingyue) Zhang
Global Project Manager - Row Crops
Director - Bioprocess Development
Pedro S. L. Coelho
Co-Founder & CEO
Co-Founder & CTO
Executive VP of Sales & Business Development
Prof. Frances Arnold
Co-Founder & Board Member
Director - Analytics
VP of Engineering
Frances Arnold wins Nobel Prize for Chemistry: Gevo, Provivi co-founder honored for directed evolution technology : Biofuels Digest